ALGS – aligos therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates [Yahoo! Finance]
Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer
Aligos Therapeutics (NASDAQ:ALGS) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Form 8-K Aligos Therapeutics, For: Jan 29
Form SCHEDULE 13G/A Aligos Therapeutics, Filed by: Woodline Partners LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.